Atopic eczema: genetics or environment?

Brunello Wuthrich 1, Antonio Cozzio 2, Antonie Roll 2, Gabriela Senti 2, Thomas Kundig 2, Peter Schmid-Grendelmeier 2
1 - Spital Zollikerberg, Allergologie, klinische Immunologie und Dermatologie, Trichtenhauserstrasse 20, 8125 Zollikerberg, Switzerland;
2 -
Ann Agric Environ Med
2007; 14 (2):
ICID: 778094
Atopic eczema (AE) is a multifactorial skin disease caused by a variety of factors such as genetic conditions, alterated skin structure, immunologic deviations and environmental factors, among others. There are two main subtypes of AE, i.e. the IgE-associated ("atopic eczema") and the non-IgE-associated type ("nonatopic eczema") with different prognosis concerning the development of respiratory diseases ("atopy march"). Recently, it was demonstrated that Filaggrin (= filament-aggregating protein, FL) is a major gene for atopic eczema. Filaggrin binds to and aggregates the keratin cytoskeleton in the epidermis. Homozygous FLG mutation leads to complete loss of filaggrin expression in skin. Half or more of children with moderate to severe AE carry FLG mutations. Moreover, filaggrin loss-of-function mutations predispose to phenotypes involved in the atopy march. The altered skin structure and a deficiency in antimicrobial peptides favour colonization with Staphylococcus aureus and yeasts (Malassezia sp.). Sensitization to the yeast occurs almost exclusively in AE patients. S. aureus enterotoxins with superantigenic activity stimulate activation of T cells and macrophages. So far, AE skin lesions are orchestrated by the local tissue expression of proinflammatory cytokines and chemokines with activation of T lymphocytes, dendritic cells, macrophages, keratinocytes, mast cells, and eosinophils which lead to the skin inflammatory responses. From the therapeutic point of view, besides emollients and local corticosteroids, topic immunomodulatory drugs (tacrolimus and pimecrolimus) have substantially improved the treatment of AE.
PMID 18247450 - click here to show this article in PubMed

Recommend this article to:


Related articles in IndexCopernicus™
     skin barrier [3 related records]
     fi laggrin [0 related records]
     genetic [69 related records]
     atopy march [0 related records]
     non-IgE-associated [0 related records]
     IgE-associated [0 related records]
     nonatopic eczema [1 related records]
     atopic eczema [4 related records]


Related articles

, ,
 Susceptibility of Human Leukocytes Antigens ...
 Background Toxoplasma gondii is an intracellular parasite which infects a widespread in humans and mammalian hosts and can cause severe disease in immune-compromised persons due to reactivation of a previous latent infection, and can be life...
S Nagaie, S Ogishima,
A method to associate all possible combinations of...
Genome-wide association studies (GWAS) and linkage analysis has identified many single nucleotide polymorphisms (SNPs) related to disease. There are many unknown SNPs whose minor allele frequencies (MAFs) as low as 0.005 having intermediate effects w...
M Tuncel,
Thyroid Stimulating Hormone Receptor...
Thyroid stimulating hormone receptor (TSHR) plays a pivotal role in thyroid hormone metabolism. It is a major controller of thyroid cell function and growth. Mutations in TSHR may lead to several thyroid diseases, most commonly hyperthyroidism. Alth...